| 000 | 01761 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517142044.0 | ||
| 264 | 0 | _c20180601 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a1878-5875 | ||
| 024 | 7 |
_a10.1016/j.biocel.2017.02.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBashash, Davood | |
| 245 | 0 | 0 |
_aAnti-tumor activity of PI3K-δ inhibitor in hematologic malignant cells: Shedding new light on resistance to Idelalisib. _h[electronic resource] |
| 260 |
_bThe international journal of biochemistry & cell biology _c04 2017 |
||
| 300 |
_a149-158 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aArsenic Trioxide |
| 650 | 0 | 4 |
_aArsenicals _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInhibitor of Apoptosis Proteins _xgenetics |
| 650 | 0 | 4 |
_aMyeloid Cell Leukemia Sequence 1 Protein _xgenetics |
| 650 | 0 | 4 |
_aOxides _xpharmacology |
| 650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPurines _xpharmacology |
| 650 | 0 | 4 |
_aQuinazolinones _xpharmacology |
| 650 | 0 | 4 | _aSurvivin |
| 700 | 1 | _aSafaroghli-Azar, Ava | |
| 700 | 1 | _aDadashi, Maryam | |
| 700 | 1 | _aSafa, Majid | |
| 700 | 1 | _aMomeny, Majid | |
| 700 | 1 | _aGhaffari, Seyed H | |
| 773 | 0 |
_tThe international journal of biochemistry & cell biology _gvol. 85 _gp. 149-158 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biocel.2017.02.007 _zAvailable from publisher's website |
| 999 |
_c26930328 _d26930328 |
||